Related Experiment Video
Updated: Feb 8, 2026

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
Published on: September 27, 2019
Cytokine modulation of atopic itch
1Center for the Study of Itch, Washington University School of Medicine, St. Louis, MO 63110 USA; Division of Dermatology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110 USA.
Atopic dermatitis (AD) involves chronic itch and skin lesions. Recent research explores how inflammation causes itch in AD, revealing potential therapeutic targets for neuroimmunologic processes.
Area of Science:
- Immunology
- Dermatology
- Neuroscience
Background:
- Atopic dermatitis (AD) is a chronic inflammatory skin condition marked by recurring lesions and persistent itch.
- Type 2 immunity plays a key role in AD pathogenesis, but itch mechanisms remain unclear.
- Inflammation is linked to atopic itch, yet the specific pathways are not fully understood.
Purpose of the Study:
- To review recent findings on the mechanisms of itch in atopic dermatitis.
- To explore how proinflammatory factors in the skin trigger itch sensations.
- To discuss potential therapeutic strategies targeting neuroimmunologic pathways in AD.
Main Methods:
- Literature review of recent studies on atopic dermatitis and itch.
- Analysis of research on type 2 immunity and skin inflammation.
- Examination of neuroimmunologic processes involved in itch perception.
Main Results:
- Proinflammatory factors released in the skin can directly elicit itch.
- Specific neuroimmunologic pathways are implicated in AD-associated itch.
- Understanding these pathways opens avenues for targeted therapies.
Conclusions:
- Recent advances illuminate the link between skin inflammation and itch in AD.
- Targeting neuroimmunologic processes offers promising therapeutic potential for AD itch.
- Further research into these mechanisms is crucial for effective AD management.
More Related Videos
06:47Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
12:58Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
Published on: May 10, 2017
Related Concept Videos
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Internal Receptors
Cooperative Allosteric Transitions
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...